https://retina.news.mail.ru/prev780x440/pic/3a/83/main42196990_0ecb7727eeef015a23c26a270e889408.jpg

control over the quality of the food and drug administration Department of health and human services, the United States withdrew an emergency permit for supply to hospitals antimalarial drugs hydroxychloroquine and chloroquine for the treatment of patients with coronavirus infection. This is stated in the document released by the Ministry on Monday, June 15.

In the release notes that on the basis of new information received by the Department no more reason to believe that these drugs are effective against the coronavirus, and that the potential benefit outweighs the potential risk, reports CNN.

In late may, the world health organization (who) has warned that the effectiveness of chloroquine against the coronavirus has not been proven.

on may 19, the President of the United States Donald trump said that in the prevention of coronavirus takes daily anti-malarial drug hydroxychloroquine.

In March, the United States has allowed the use of chloroquine and hydroxychloroquine for the treatment of coronavirus infection.

the world health organization (who) on 11 March announced the outbreak of the novel coronavirus and disease caused by them COVID-19 pandemic. According to June 15, just world marked 8 026 778 cases of infection, recovered — 4 146 770 people who died — 436,228.